Molina Healthcare Gestion

Gestion contrôle des critères 3/4

Nous ne disposons actuellement pas d’informations suffisantes sur le PDG.

Informations clés

Joe Zubretsky

Directeur général

US$21.5m

Rémunération totale

Pourcentage du salaire du PDG	7.0%
Durée du mandat du directeur général	7yrs
Propriété du PDG	0.6%
Durée moyenne d'occupation des postes de direction	6yrs
Durée moyenne du mandat des membres du conseil d'administration	9.3yrs

Mises à jour récentes de la gestion

Recent updates

Analyse de la rémunération des PDG

Comment la rémunération de Joe Zubretsky a-t-elle évolué par rapport aux bénéfices de Molina Healthcare?
Date	Rémunération totale	Salaire	Bénéfices de l'entreprise
Sep 30 2024	n/a	n/a	US$1b
Jun 30 2024	n/a	n/a	US$1b
Mar 31 2024	n/a	n/a	US$1b
Dec 31 2023	US$21m	US$2m	US$1b
Sep 30 2023	n/a	n/a	US$931m
Jun 30 2023	n/a	n/a	US$916m
Mar 31 2023	n/a	n/a	US$855m
Dec 31 2022	US$22m	US$2m	US$792m
Sep 30 2022	n/a	n/a	US$839m
Jun 30 2022	n/a	n/a	US$752m
Mar 31 2022	n/a	n/a	US$689m
Dec 31 2021	US$20m	US$2m	US$659m
Sep 30 2021	n/a	n/a	US$590m
Jun 30 2021	n/a	n/a	US$632m
Mar 31 2021	n/a	n/a	US$723m
Dec 31 2020	US$18m	US$1m	US$673m
Sep 30 2020	n/a	n/a	US$807m
Jun 30 2020	n/a	n/a	US$797m
Mar 31 2020	n/a	n/a	US$717m
Dec 31 2019	US$18m	US$1m	US$737m
Sep 30 2019	n/a	n/a	US$770m
Jun 30 2019	n/a	n/a	US$792m
Mar 31 2019	n/a	n/a	US$798m
Dec 31 2018	US$15m	US$1m	US$707m
Sep 30 2018	n/a	n/a	US$244m
Jun 30 2018	n/a	n/a	-US$50m
Mar 31 2018	n/a	n/a	-US$482m
Dec 31 2017	US$20m	US$175k	-US$512m

Rémunération vs marché: La rémunération totale de Joe ($USD 21.49M ) est supérieure à la moyenne des entreprises de taille similaire sur le marché German ($USD 4.95M ).

Rémunération et revenus: La rémunération de Joe a été cohérente avec les performances de l'entreprise au cours de l'année écoulée.

PDG

Joe Zubretsky (67 yo)

7yrs

Titularisation

US$21,491,723

Compensation

Mr. Joseph Michael Zubretsky, also known as Joe, has been President, Chief Executive Officer and Director of Molina Healthcare, Inc. since November 6, 2017. Mr. Zubretsky served as President and Chief Exec...

Équipe de direction

Nom	Position	Titularisation	Compensation	Propriété
Joseph Zubretsky	President	7yrs	US$21.49m	0.61% € 108.3m
Mark Keim	Senior EVP	3.8yrs	US$6.40m	0.083% € 14.7m
James Woys	Senior EVP & COO	1.5yrs	US$5.54m	0.094% € 16.6m
Maurice Hebert	Chief Accounting Officer	6.2yrs	US$1.27m	0.017% € 2.9m
Jeffrey Barlow	Chief Legal Officer & Corporate Secretary	14.3yrs	US$4.89m	0.12% € 20.5m
Jeffrey Geyer	Head of Investor Relations	no data	pas de données	pas de données
Joann Zarza-Garrido	Vice President of Compliance	18.3yrs	pas de données	pas de données
Larry Anderson	Executive VP & Chief Human Resources Officer	5.8yrs	pas de données	pas de données
Keith Wilson	Chief Medical Officer	10.3yrs	pas de données	pas de données
John Kotal	Chief Operating Officer of Molina Healthcare of California	no data	pas de données	pas de données
David Reynolds	Senior Vice President of Health Plans	4.8yrs	pas de données	pas de données
Jason Dees	Executive VP of Marketplace & Chief Medical Officer	4.8yrs	pas de données	pas de données

6.0yrs

Durée moyenne de l'emploi

61yo

Âge moyen

Gestion expérimentée: L'équipe dirigeante de MHG est chevronnée et expérimentée (6 années d'ancienneté moyenne).

Membres du conseil d'administration

Nom	Position	Titularisation	Compensation	Propriété
Joseph Zubretsky	President	7yrs	US$21.49m	0.61% € 108.3m
Dale Wolf	Independent Non-Executive Chairman of the Board	11.7yrs	US$545.46k	0.027% € 4.8m
Daniel Cooperman	Independent Director	11.7yrs	US$342.96k	0.011% € 1.9m
Steven Orlando	Independent Director	19yrs	US$380.46k	0.034% € 6.1m
Ronna Romney	Independent Vice Chair of the Board	21.8yrs	US$385.46k	0.030% € 5.4m
Barbara Brasier	Independent Director	5.5yrs	US$347.96k	0.0071% € 1.2m
Richard Zoretic	Independent Director	6.3yrs	US$347.96k	0.012% € 2.1m
Stephen Lockhart	Independent Director	3.5yrs	US$332.96k	0.0046% € 805.4k
Richard Schapiro	Independent Director	9.3yrs	US$357.96k	0.020% € 3.6m

9.3yrs

Durée moyenne de l'emploi

68yo

Âge moyen

Conseil d'administration expérimenté: Les membres du conseil d'administration de MHG sont considérés comme expérimentés (ancienneté moyenne 9.3 ans).

Molina Healthcare Gestion

Gestion contrôle des critères 3/4

Informations clés

Mises à jour récentes de la gestion

Insider recently sold €1.7m worth of stock

Molina Healthcare, Inc., Annual General Meeting, May 01, 2024

Senior EVP recently sold €5.4m worth of stock

Insider recently sold €3.5m worth of stock

Molina Healthcare, Inc. Names Aaron Dunkel as Plan President for Kansas

Molina Healthcare, Inc. Announces Management Promotions

Recent updates

Third quarter 2024 earnings released: EPS: US$5.65 (vs US$4.24 in 3Q 2023)

Investor sentiment deteriorates as stock falls 15%

Molina Healthcare, Inc. to Report Q3, 2024 Results on Oct 23, 2024

Insider recently sold €1.7m worth of stock

New minor risk - Share price stability

Second quarter 2024 earnings released: EPS: US$5.17 (vs US$5.36 in 2Q 2023)

Molina Healthcare, Inc. Re-Affirms Earnings Guidance for the Full Year 2024

Molina Healthcare, Inc. (NYSE:MOH) agreed to acquire Connecticare Holding Company, Inc from EmblemHealth Inc for $350 million.

Molina Healthcare, Inc. to Report Q2, 2024 Results on Jul 24, 2024

Molina Healthcare, Inc. Re-Affirms Earnings Guidance for the Full Year 2024

Molina Healthcare, Inc. Provides Earnings Guidance for the Full Year 2024

First quarter 2024 earnings released: EPS: US$5.16 (vs US$5.58 in 1Q 2023)

Molina Healthcare, Inc., Annual General Meeting, May 01, 2024

Molina Healthcare, Inc. to Report Q1, 2024 Results on Apr 24, 2024

New minor risk - Insider selling

Senior EVP recently sold €5.4m worth of stock

Full year 2023 earnings released: EPS: US$18.78 (vs US$13.70 in FY 2022)

Molina Healthcare, Inc. Provides Earnings Guidance for the Year 2024

Molina Healthcare, Inc. to Report Q4, 2023 Results on Feb 07, 2024

Third quarter 2023 earnings released: EPS: US$4.22 (vs US$3.99 in 3Q 2022)

Molina Healthcare, Inc. Affirms Earnings Guidance for the Year 2023

Molina Healthcare, Inc. to Report Q3, 2023 Results on Oct 25, 2023

Insider recently sold €3.5m worth of stock

Second quarter 2023 earnings released: EPS: US$5.34 (vs US$4.29 in 2Q 2022)

Molina Healthcare, Inc. Names Aaron Dunkel as Plan President for Kansas

Molina Healthcare, Inc. (NYSE:MOH) entered into a Stock Purchase Agreement to acquire Central Health Plan of California, Inc. and Universal Care, Inc. from Bright Health Company of California, Inc. for $600 million.

Molina Healthcare and Partners Share Results of Obstetrics Health Care Model Incorporating Artificial Intelligence

Molina Healthcare, Inc. to Report Q2, 2023 Results on Jul 26, 2023

Molina Healthcare, Inc. Announces Management Promotions

First quarter 2023 earnings released: EPS: US$5.53 (vs US$4.45 in 1Q 2022)

Full year 2022 earnings released: EPS: US$13.55 (vs US$11.40 in FY 2021)

Molina Healthcare, Inc. Provides Earnings Guidance for the Year 2023

Molina Healthcare Appoints Frank Clepper as Plan President

Molina Healthcare, Inc. to Report Q4, 2022 Results on Feb 08, 2023

Key Executive recently sold €809k worth of stock

Insufficient new directors

Independent Director recently sold €1.1m worth of stock

Third quarter 2022 earnings released: EPS: US$3.95 (vs US$2.47 in 3Q 2021)

Molina Healthcare, Inc. Revises Earnings Guidance for the Year 2022

Molina Healthcare, Inc. to Report Q3, 2022 Results on Oct 26, 2022

Insider recently sold €5.1m worth of stock

Independent Director recently sold €178k worth of stock

Insider recently sold €8.1m worth of stock

Second quarter 2022 earnings released: EPS: US$4.25 (vs US$3.21 in 2Q 2021)

Molina Healthcare, Inc. Revises Earnings Guidance for the Year 2022

Molina Healthcare, Inc. (NYSE: MOH) agreed to acquire Substantially All the Assets Of My Choice Wisconsin for approximately $150 million.

Molina Healthcare, Inc. to Report Q2, 2022 Results on Jul 27, 2022

Insufficient new directors

First quarter 2022 earnings released: EPS: US$4.40 (vs US$3.95 in 1Q 2021)

Molina Healthcare, Inc. Revises Earnings Guidance for the Year Ending December 31, 2022

Insider recently sold €1.4m worth of stock

Full year 2021 earnings: EPS in line with analyst expectations despite revenue beat

Molina Healthcare, Inc. Provides Earnings Guidance for the Year 2022

Third quarter 2021 earnings released: EPS US$2.44 (vs US$3.15 in 3Q 2020)

Second quarter 2021 earnings released: EPS US$3.17 (vs US$4.71 in 2Q 2020)

Insider recently sold €675k worth of stock

Insider recently sold €659k worth of stock

First quarter 2021 earnings released: EPS US$3.89 (vs US$2.96 in 1Q 2020)

Molina Healthcare, Inc. Revises Earnings Guidance for the Year 2021

Independent Director recently sold €152k worth of stock

Molina Healthcare, Inc. to Report Q1, 2021 Results on Apr 28, 2021

Molina Healthcare, Inc. Announces Executive Changes

Full year 2020 earnings released: EPS US$11.24 (vs US$11.85 in FY 2019)

Revenue misses expectations

the Molinacares Accord Announces A New Collaboration with the American Academy of Family Physicians

Molina Healthcare, Inc. Revises Earnings Guidance for the Year 2021

Investor sentiment improved over the past week

Molina Healthcare, Inc. Announces Appointment of Brian Maddy as Plan President of Oklahoma Operations

New 90-day high: €190